Meihua International Medical Technologies
(OTC) MHUAF
Meihua International Medical Technologies Financials at a Glance
Market Cap
$7.17M
Revenue (TTM)
$183.80M
Net Income (TTM)
$18.55M
EPS (TTM)
$30.65
P/E Ratio
0.27
Dividend
$0.00
Beta (Volatility)
1.12 (Average)
Dividend
$0.00
Beta (Volatility)
1.12 (Average)
Price
$8.36
Volume
13
Open
$6.00
Price
$8.36
Volume
13
Open
$6.00
Previous Close
$8.36
Daily Range
$6.00 - $8.85
52-Week Range
$2.05 - $64.00
Dividend
$0.00
Beta (Volatility)
1.12 (Average)
Price
$8.36
Volume
13
Open
$6.00
Previous Close
$8.36
Daily Range
$6.00 - $8.85
52-Week Range
$2.05 - $64.00
MHUAF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Meihua International Medical Technologies
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
619
CEO
Wang Xin
Website
www.meihuamed.comHeadquarters
Yangzhou, 225000, CN
MHUAF Financials
Key Financial Metrics (TTM)
Gross Margin
34%
Operating Margin
13%
Net Income Margin
10%
Return on Equity
6%
Return on Capital
7%
Return on Assets
5%
Earnings Yield
3.70%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$7.17M
Shares Outstanding
857.90K
Volume
13
Short Interest
0.00%
Avg. Volume
1.17K
Financials (TTM)
Gross Profit
$33.30M
Operating Income
$14.31M
EBITDA
$15.70M
Operating Cash Flow
$14.64M
Capital Expenditure
$133.55K
Free Cash Flow
$14.50M
Cash & ST Invst.
$15.96M
Total Debt
$7.95M
Meihua International Medical Technologies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$37.98M
-21.2%
Gross Profit
$12.61M
-26.2%
Gross Margin
33.21%
N/A
Market Cap
$7.17M
N/A
Market Cap/Employee
$11.59K
N/A
Employees
619
N/A
Net Income
$3.15M
-55.5%
EBITDA
$3.51M
-63.1%
Quarterly Fundamentals
Net Cash
$4.10M
-61.6%
Accounts Receivable
$117.67M
+20.8%
Inventory
$1.10M
-33.2%
Long Term Debt
$0.00
N/A
Short Term Debt
$11.45M
+59.6%
Return on Assets
4.87%
N/A
Return on Invested Capital
7.07%
N/A
Free Cash Flow
$9.91M
+0.9%
Operating Cash Flow
$9.90M
-82.5%